Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Expert Review of Vaccines
|
August 3, 2004
ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development
Mary A Marovich
Current Opinion in HIV and AIDS
|
September 17, 2016
Pox-Protein Public Private Partnership program and upcoming HIV vaccine efficacy trials
Nina D Russell, Mary A Marovich
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2013
Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection
Kobporn Boonnak, Bonnie M Slike, Gina C Donofrio, et al.
Plos Neglected Tropical Diseases
|
October 21, 2015
The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy
Ines Lakhal-Naouar, Bonnie M Slike, Naomi E Aronson, et al.
Journal of Translational Medicine
|
December 14, 2011
Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications
Jeffrey R Currier, Merlin L Robb, Nelson L Michael, et al.
Journal of Virology
|
December 3, 2010
Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection
Kobporn Boonnak, Kaitlyn M Dambach, Gina C Donofrio, et al.
The Lancet. Infectious Diseases
|
October 2, 2010
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B Halstead, Suresh Mahalingam, Mary A Marovich, et al.
Mbio
|
December 15, 2011
Complement-mediated neutralization of dengue virus requires mannose-binding lectin
Panisadee Avirutnan, Richard E Hauhart, Mary A Marovich, et al.
Journal of Virology
|
February 1, 2005
Differential effects of dengue virus on infected and bystander dendritic cells
Dupeh R Palmer, Peifang Sun, Christina Celluzzi, et al.
Clinical & Developmental Immunology
|
August 28, 2004
Specific antibody production by blood B cells is retained in late stage drug-naïve HIV-infected Africans
Lydie Béniguel, Evelyne Bégaud, Fabrice Cognasse, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Expert Review of Vaccines
|
August 3, 2004
ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development
Mary A Marovich
Current Opinion in HIV and AIDS
|
September 17, 2016
Pox-Protein Public Private Partnership program and upcoming HIV vaccine efficacy trials
Nina D Russell, Mary A Marovich
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2013
Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection
Kobporn Boonnak, Bonnie M Slike, Gina C Donofrio, et al.
Plos Neglected Tropical Diseases
|
October 21, 2015
The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy
Ines Lakhal-Naouar, Bonnie M Slike, Naomi E Aronson, et al.
Journal of Translational Medicine
|
December 14, 2011
Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications
Jeffrey R Currier, Merlin L Robb, Nelson L Michael, et al.
Journal of Virology
|
December 3, 2010
Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection
Kobporn Boonnak, Kaitlyn M Dambach, Gina C Donofrio, et al.
The Lancet. Infectious Diseases
|
October 2, 2010
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B Halstead, Suresh Mahalingam, Mary A Marovich, et al.
Mbio
|
December 15, 2011
Complement-mediated neutralization of dengue virus requires mannose-binding lectin
Panisadee Avirutnan, Richard E Hauhart, Mary A Marovich, et al.
Journal of Virology
|
February 1, 2005
Differential effects of dengue virus on infected and bystander dendritic cells
Dupeh R Palmer, Peifang Sun, Christina Celluzzi, et al.
Clinical & Developmental Immunology
|
August 28, 2004
Specific antibody production by blood B cells is retained in late stage drug-naïve HIV-infected Africans
Lydie Béniguel, Evelyne Bégaud, Fabrice Cognasse, et al.
Page
of 6